KIF20A and gastric cancer: Yi Sheng and collaborators have demonstrated that KIF20A’s increased expression in gastric cancer correlates with enhanced cell proliferation, poor overall survival, and higher histological grades, highlighting its oncogenic role and its potential as a prognostic and therapeutic target [32].